H.R. 4792
Referred to CommitteeCountering Communist China Act
Latest Action
Referred to the Subcommittee on Energy and Mineral Resources.
9/3/2021 • House
Summary
Countering Communist China Act
This bill addresses issues related to China, tax incentives, and other topics.
The bill imposes visa- and property-blocking sanctions on certain entities and individuals that (1) are involved in acts of malign disinformation on behalf of a foreign government or political party, or (2) have engaged in a pattern of significant infringement of intellectual property belonging to a U.S. entity or individual. It also authorizes sanctions on developers and owners of software that makes unauthorized transmissions of user data to servers that are located in China and are accessible by China's government.
The bill also
- provides tax incentives for relocating pharmaceutical, medical supply, or medical device manufacturing to the United States, including by allowing accelerated depreciation of nonresidential real property acquired in connection with such relocation;
- eliminates the five-year amortization requirement for research and experimental expenditures scheduled to begin in 2022, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred;
- prohibits an institution of higher education from receiving certain federal funds if the institution has a contractual partnership with an entity controlled by China's government or organized under China's laws;
- modifies presumptions and evidentiary standards in administrative patent validity challenges;
- bars China from asserting sovereign immunity in certain instances;
- requires U.S. representatives to the International Monetary Fund (IMF) to take certain actions, such as opposing any increase to the weight given to China's currency when determining the value of IMF Special Drawing Rights; and
- permanently rescinds unobligated funds previously made available for certain economic relief programs related to COVID-19.
Introduced in House • 7/29/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (56)
Party Breakdown
Sponsor
Cosponsors (55)
Bill Journey
Originated in the House
Introduced
July 29, 2021
Referred to the Subcommittee on Trade.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (33)
H.R. 4887
To amend section 1603 of title 28, United States Code, to except the People's Republic of China as a defined foreign state.
H.R. 4912
CCP Businesses Registered Agent Act
H.Con.Res. 36
Establishing the Joint Select Committee on the Events and Activities Surrounding China's Handling of the 2019 Novel Coronavirus.
H.R. 354
CCP Visa Disclosure Act of 2021
H.R. 497
To prohibit the use of funds to seek membership in the World Health Organization or to provide assessed or voluntary contributions to the World Health Organization.
H.R. 1094
Safe Career Transitions for Intelligence and National Security Professionals
H.R. 1137
Opposing Business with Chinese Military Companies Act
H.R. 1304
American Innovation and R&D Competitiveness Act of 2021
H.R. 1595
Keep Huawei on the Entity List Act
H.R. 2318
Red Tape Reduction Act
H.R. 2558
ALIGN Act
H.R. 3011
Holding Chinese Military Companies Accountable Act
H.R. 3018
Chinese Communist Party (CCP) Politburo Accountability Act
H.R. 3049
No Communist Countries Participating in Lobbying Act
H.R. 3074
No Taxpayer Funded Platform for Chinese Communists Act
H.R. 3082
National Security Through America’s Resources and Permitting Reform Act of 2021
H.R. 3146
SAVE Act of 2021
H.R. 3343
Protecting America From Spies Act
H.R. 3506
21st Century Dollar Act
H.R. 3866
Chinese Currency Accountability Act of 2021
H.R. 4327
Protect American Trade Secrets Act of 2021
H.R. 4711
International Pharmaceutical Supply Chain Security Agreement Act of 2021
H.R. 4734
American Science First Act
H.R. 4793
Protecting Personal Data from Foreign Adversaries Act
H.R. 4840
End Misleading Cultural Exchanges Act
H.R. 4868
TIGER Act
H.R. 5046
Holding Countries Accountable for Negligent Chemical and Biological Programs Act
S. 1166
ALIGN Act
S. 1800
Human-Animal Chimera Prohibition Act of 2021
S. 3038
Exposing China’s Belt and Road Investment in America Act of 2021
H.R. 3542
Human-Animal Chimera Prohibition Act of 2021
H.R. 5806
Exposing China’s Belt and Road Investment in America Act of 2021
H.R. 6710
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
Committees
Natural Resources Committee
House
Foreign Affairs Committee
House
Transportation and Infrastructure Committee
House
Energy and Commerce Committee
House
Ways and Means Committee
House
Armed Services Committee
House
Education and Workforce Committee
House
Science, Space, and Technology Committee
House
Rules Committee
House
Agriculture Committee
House
Intelligence (Permanent Select) Committee
House
Financial Services Committee
House
Oversight and Government Reform Committee
House
Judiciary Committee
House